In addition, EphA2 is overexpressed in various cancers, including breast cancer [2], esophageal cancer [3], melanoma [4], lung cancer [5], prostate cancer [6], ovarian cancer [7,8], and endometrial cancer [9,10]. This evidence concerns the gene EPHA2 and ovarian carcinoma.